Navigation Links
Mirati Therapeutics Reports Second Quarter 2014 Financial Results and Provides Business Update
Date:8/8/2014

m is using a proven blueprint for developing targeted oncology medicines to advance and maximize the value of its pipeline of drug candidates, including MGCD265 and MGCD516, which are orally bioavailable, multi-targeted kinase inhibitors with distinct target profiles, and mocetinostat, an orally bio-available, spectrum-selective histone deacetylase inhibitor. More information is available at www.mirati.com.

Forward Looking Statements
Certain statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, may constitute forward-looking information and forward-looking statements (collectively "forward-looking statements" within the meaning of applicable securities laws). Such statements, based as they are on the current expectations of management of Mirati and upon what management believes to be reasonable assumptions based on information currently available to it, inherently involve numerous risks and uncertainties, known and unknown, many of which are beyond Mirati's control. Such statements can usually be identified by the use of words such as "may", "would", "believe", "intend", "plan", "anticipate", "estimate" and other similar terminology, or state that certain actions, events or results "may" or "would" be taken, occur or be achieved. Forward-looking statements in this release include, but are not limited to, statements regarding the timing of initiating and reporting data from clinical trials, the potential for MGCD265 to show signals of activity in Met and Axl pathways and the potential for accelerated approval pathways.

Whether actual results and developments will conform with our expectations and predictions is subject to a number of risks, assumptions and uncertainties, many of which are beyond our control, and the effects of which can be difficult to predict. These risks include those inherent in drug development, whether Mirati will
'/>"/>

SOURCE Mirati Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Mirati Presents Clinical Response Results of Mocetinostat in Combination with Azacitidine as a Treatment for MDS
2. Updated Presentation Time: Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
3. Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
4. Mirati Therapeutics Reports Third Quarter 2013 Financial Results
5. Mirati Therapeutics Prices Public Offering Of Common Stock
6. Mast Therapeutics To Present At The Canaccord Genuity 34th Annual Growth Conference On August 14th
7. Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014
8. PTC Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
9. Pivotal Therapeutics To Explore Potential Commercial Partnership Opportunities in China
10. Relmada Therapeutics, Inc. Completes Name Change and Announces New Ticker
11. PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  When ... along the side of his neck, he ... took a couple weeks off from weight ... go away.                               A ... 26, was referred to Michel Kliot, ...
(Date:5/21/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today that its Board of Directors has ... 2015 of $0.03 per share of common stock outstanding.  ... be paid on June 19, 2015 to all common ... ex-dividend date for the quarterly dividend is June 10, ...
(Date:5/21/2015)... , 21. Mai 2015 /PRNewswire/ ... DPRX ), ein Unternehmen für Arzneimittel ... die Entwicklung und Vermarktung von Locilex® ... kündigte heute eine wissenschaftliche Posterpräsentation an, ... des Unternehmens vorstellt, OneStep-1 und OneStep-2, ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... DIEGO , May 26 Anadys Pharmaceuticals, Inc. ... Lazard Freres & Co. LLC as its strategic advisor as ... stockholders from its non-nucleoside polymerase inhibitor, ANA598, in development for ... and antiviral response data at the conclusion of 12 weeks ...
... Agency,s consumer health information , , , ... May 26 The U.S. Food and Drug Administration announced today that it ... information. , , , ... , , ...
Cached Medicine Technology:Anadys Retains Lazard as Strategic Advisor 2Anadys Retains Lazard as Strategic Advisor 3Anadys Retains Lazard as Strategic Advisor 4Anadys Retains Lazard as Strategic Advisor 5FDA Announces Collaboration With Drugs.com 2
(Date:5/22/2015)... 22, 2015 DMG Productions announces the ... to broadcast on Friday, May 29, 2015 at 7:30 ... , In this episode Innovations will explore Interstate Restoration, ... business quickly through disaster recovery and restoration. , Additionally, ... works collaboratively to develop and deliver training and education ...
(Date:5/22/2015)... Steven Winter Associates (SWA) Vice President ... selected by Consulting-Specifying Engineer (CSE) magazine as a young ... in the May/June issue of the publication. , This ... 40 and younger who have, and continue to make ... in other areas of their professional and personal endeavors. ...
(Date:5/22/2015)... A new program for the "In America" television ... Physical Therapy. , James Earl Jones will host ... physical therapy and discusses how the exercises can decrease ... of ailments and injuries. Physical therapists work with ... enhances daily activities such as house cleaning and shopping, ...
(Date:5/22/2015)... In efforts to offer full and robust ... muscles stretches has been a large focus over the ... complete, Chunk Fitness envisions a mid-June launch of these ... released at a later point in time. The current ... . , About the Company: Chunk Fitness was founded ...
(Date:5/22/2015)... Pro3rd Impression is a collection ... Cut Pro X. Pro3rd Impression's clean and simplistic layouts ... on-screen-controls allow users to customize scale, position and rotation ... much more can be edited using the controls located ... comes packed with 30 simplistically elegant lower thirds ...
Breaking Medicine News(10 mins):Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2
... During the current recession, small businesses turn to reflexology and aromatherapy, ... promote well-being and increase productivity. Scientific studies back the anecdotal evidence ... ... Colo. (PRWEB) January 5, 2009 -- Reflexology and Aromatherapy increase the ...
... Nepstar Chain,Drugstore Ltd. (NYSE: NPD ) ... in China based on the number of directly ... Wade, a retail industry veteran,with an outstanding track ... the Company announced the appointment of Mr. William ...
... the snowy season , , SATURDAY, Jan. 4 (HealthDay News) -- ... as you take a few simple precautions, says the National ... on how to stay active and safe during cold weather ... constricts muscles, so you need to allow enough time for ...
... cancer prevention than vitamin supplementation. , ... Phoenix, AZ ... the Journal of the National Cancer Institute confirmed that vitamin supplementation ... study comes on the heels of numerous studies which all draw ...
... New Study Reveals the Most Common Reasons Why Total ... year thousands of patients undergo total hip replacement surgery ... hip disease and other related hip problems. According ... issue of The Journal of Bone and Joint ...
... Jan. 2 The owners of MAKE IT FIT(TM),( ... all Mississippians build healthier lifestyles in 2009 by donating,their ... Johnson,are offering all residents of the Magnolia state an ... if they sign up during the hours of,8am to ...
Cached Medicine News:Health News:Workplace Creativity Activated by Reflexology, Chair Massage 2Health News:Workplace Creativity Activated by Reflexology, Chair Massage 3Health News:China Nepstar Chain Drugstore Announces New Management Team Members 2Health News:China Nepstar Chain Drugstore Announces New Management Team Members 3Health News:China Nepstar Chain Drugstore Announces New Management Team Members 4Health News:Winter Workouts Are Cool 2Health News:Treadmill Desks More Effective in Cancer Prevention for Women than Vitamin C, E and Beta Carotene Supplementation 2Health News:Treadmill Desks More Effective in Cancer Prevention for Women than Vitamin C, E and Beta Carotene Supplementation 3Health News:Replacing Your Total Hip Replacement 2Health News:Replacing Your Total Hip Replacement 3Health News:MAKE IT FIT(TM) Offers Virtually Free Fitness Service to All Mississippi Residents on 'Make Mississippi Fit Day' 2
... used to evaluate both low contrast acuity and ... 12.5%) of LogMAR acuity (20/16 to 20/100) are ... the two spatial frequencies of 6 and 12 ... cataract documentation because eye doctors can document cataract ...
... test face is widely used for in or ... presents standard visual acuity from 20/15 to 20/200, ... cycles/degree) and a real-world driver's scene. , ,The ... it provides a standard acuity score, a functional ...
The compact, simple-to-use ECG for medical professionals....
The first book to translate key medical data into clear guidelines capturing the highest treatment standards for heart disease....
Medicine Products: